24 completed, 3 recruiting, 2 terminated, 1 suspended. 31 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 31 | Completed 24, Recruiting 3, Terminated 2, Suspended 1, Unknown 1 |
| Phase 2 | 6 | Completed 3, Recruiting 2, Terminated 1 |
Follow Lopinavir: new trials by email Literature Review of Lopinavir trials Research Report on Lopinavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lopinavir/Ritonavir in PLWH With High-Grade AIN Lopinavir / Ritonavir - High-Grade Anal Intraepithelial Neoplasia | Phase 1 | Recruiting | University of Wisconsin, Madison | 21 | 2023-12-19 | 2026-05-15 |
| A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors DB-1311, Lopinavir and Ritonavir Tablets, itraconazole - Advanced Solid Tumors | Phase 1 / Phase 2 | Recruiting | DualityBio Inc. | 862 | 2023-08-17 | 2026-10-21 |
| Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions Lopinavir/Ritonavir 200 mg/50 mg Film Tablet, Lopinavir/Ritonavir 200 mg/50 mg Film Coated Tablet - Bioequivalence | Phase 1 | Completed | World Medicine ILAC SAN. ve TIC. A.S. | 30 | 2020-04-30 | 2020-12-31 |
| LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab - COVID-19, Hospitalized COVID-19 Patients | Phase 1 | Unknown | Lebanese University | 1000 | 2020-03-28 | 2024-02-06 |
| Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 Wharton's jelly derived Mesenchymal stem cells., Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy) - Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Terminated | BioXcellerator | 6 | 2020-01-13 | 2024-08-27 |
| CiPA Phase 1 ECG Biomarker Validation Study Ranolazine, Verapamil, Lopinavir / Ritonavir - Drug-induced QT Prolongation, Pharmacokinetics | Phase 1 | Completed | Food and Drug Administration (FDA) | 60 | 2017-03-14 | 2020-01-18 |
| PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers 50mg NANO-efavirenz, 400mg NANO-Lopinavir, 200mg NANO-Lopinavir - HIV | Phase 1 | Suspended | St Stephens Aids Trust | 50 | 2015-11-01 | 2016-12-07 |
| Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nevirapine (NVP), Lopinavir/Ritonavir (LPV/r) - HIV Infection | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 1120 | 2015-01-23 | 2026-09-09 |
| Changes in Insulin Resistance in Healthy Volunteers on STRIBILDĀ® Medication Tenofovir disaproxil fumarate/emtricitabine/elvitegravir/cobicistat, Tenofovir disaproxil fumarate/emtricitabine + Lopinavir/ritonavir, Tenofovir disaproxil fumarate/emtricitabine + ritonavir-boosted darunavir - Insulin Resistance | Phase 1 | Completed | Technical University of Munich | 30 | 2014-07-01 | 2014-11-05 |
| Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants Daclatasvir, Darunavir, Ritonavir - Hepatitis C | Phase 1 | Completed | Bristol-Myers Squibb | 49 | 2014-06-01 | 2015-11-30 |
| Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected Lopinavir/ritonavir, Emtricitabine/tenofovir disoproxil fumarate, Efavirenz - HIV-1 Infection, Pf Subclinical Parasitemia | Phase 1 / Phase 2 | Completed | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 52 | 2014-01-10 | 2019-08-06 |
| Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole Isavuconazole, Lopinavir/ritonavir - Pharmacokinetics of Isavuconazole, Pharmacokinetics of Lopinavir/Ritonavir | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 68 | 2012-06-01 | 2015-02-23 |
| Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin PA-824, Efavirenz (EFV), Lopinavir/Ritonavir (LPV/r) - Tuberculosis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 52 | 2012-05-01 | 2021-11-05 |
| The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers Fenofibrate, Ritonavir, Lopinavir/Ritonavir - HIV, Fenofibrate | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 25 | 2010-05-13 | 2019-12-09 |
| Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir) Kaletra (lopinavir/ritonavir), African Potato (hypoxis obtusa) - Drug Interactions, Human Immunodeficiency Virus | Phase 1 | Completed | University of California, San Francisco | 18 | 2010-02-01 | 2015-05-07 |
| Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. lopinavir/ritonavir - Acquired Immunodeficiency Syndrome | Phase 1 | Completed | Kirby Institute | 22 | 2009-10-01 | 2011-03-29 |
| Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs darunavir/ritonavir, lopinavir/ritonavir, Midazolam - Healthy Subjects, Infection, Human Immunodeficiency Virus | Phase 1 | Completed | GlaxoSmithKline | 24 | 2009-06-01 | 2010-11-03 |
| GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir Darunavir, Etravirine, Ritonavir - Healthy Volunteer | Phase 1 | Completed | ViiV Healthcare | 17 | 2009-04-01 | 2012-02-22 |
| Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. Eltrombopag, Lopinavir/Ritonavir, Eltrombopag and Lopinavir/Ritonavir - Hepatitis C | Phase 1 | Completed | GlaxoSmithKline | 40 | 2009-01-19 | 2017-11-14 |
| TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers. Etravirine; Lopinavir; Ritonavir - HIV | Phase 1 | Completed | Tibotec Pharmaceuticals, Ireland | 16 | 2008-09-01 | 2011-06-09 |
Showing 20 of 31. Sign in to see all of them.
HIV Infections (11) · Acquired Immunodeficiency Syndrome (4) · Hepatitis C (2) · Malaria (2) · Tuberculosis (2) · COVID-19 (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Coronavirus Infections (1) · Disease Progression (1) · Esophageal Squamous Cell Carcinoma (1) · Hypertriglyceridemia (1) · Infections (1) · Inflammation (1) · Insulin Resistance (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · Abbott (3) · GlaxoSmithKline (2) · St Stephens Aids Trust (2) · University of California, San Francisco (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Astellas Pharma Global Development, Inc. (1) · BioXcellerator (1) · Bristol-Myers Squibb (1) · DualityBio Inc. (1) · Food and Drug Administration (FDA) (1) · Fran Aweeka (1) · Germans Trias i Pujol Hospital (1) · Kirby Institute (1) · Lebanese University (1)
United States (20) · Puerto Rico (3) · United Kingdom (3) · Brazil (2) · Kenya (2) · Malawi (2) · Uganda (2) · Argentina (1) · Australia (1) · China (1) · Colombia (1) · Germany (1) · Haiti (1) · Lebanon (1) · Netherlands (1)
Alfredo Hernandez-Ruiz, MSc (1) · Angela DM Kashuba, PharmD (1) · Angela Nilius, MD (1) · Bonaventura Clotet, MD, PhD (1) · Carlos Sanabria, MD (1) · Christoph D Spinner, MD (1) · David M Burger (1) · Douglas Shaffer, MD, MHS (1) · Ellen Chadwick, MD (1) · Ellen G. Chadwick, MD (1) · Evie Carchman, MD, FACS (1) · Francesca Aweeka, Pharm.D. (1) · Francesca T Aweeka, Pharm.D. (1)
PMID 17436219, PMID 18625762, PMID 18647794, PMID 19209098, PMID 20056686, PMID 21172791, PMID 21297419, PMID 22288567, PMID 22555165, PMID 23494984, PMID 24957823, PMID 30447156, PMID 34693933
2004 (1), 2014 (1), U01AI068636 (1), UM1AI068616 (1), UM1AI068632 (1), UM1AI106716 (1)